[Trial of combined intermittent chemotherapy in prostatic cancers. Estrogen resistant metastases].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008357:Mannomustine / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D004967:Estrogens; D008357:Mannomustine; D005472:Fluorouracil
Essai d'une chimiothérapie associée discontinue dans les cancers de la prostate. Métastases oestro-géno résistantes